426 related articles for article (PubMed ID: 25944088)
1. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
Major JL; Salih M; Tuana BS
J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088
[TBL] [Abstract][Full Text] [Related]
2. The E2F6 repressor activates gene expression in myocardium resulting in dilated cardiomyopathy.
Westendorp B; Major JL; Nader M; Salih M; Leenen FH; Tuana BS
FASEB J; 2012 Jun; 26(6):2569-79. PubMed ID: 22403008
[TBL] [Abstract][Full Text] [Related]
3. E2F6 Impairs Glycolysis and Activates BDH1 Expression Prior to Dilated Cardiomyopathy.
Major JL; Dewan A; Salih M; Leddy JJ; Tuana BS
PLoS One; 2017; 12(1):e0170066. PubMed ID: 28085920
[TBL] [Abstract][Full Text] [Related]
4. Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing alpha1B-adrenergic receptors.
Iaccarino G; Keys JR; Rapacciuolo A; Shotwell KF; Lefkowitz RJ; Rockman HA; Koch WJ
J Am Coll Cardiol; 2001 Aug; 38(2):534-40. PubMed ID: 11499749
[TBL] [Abstract][Full Text] [Related]
5. β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway.
Vidal M; Wieland T; Lohse MJ; Lorenz K
Cardiovasc Res; 2012 Nov; 96(2):255-64. PubMed ID: 22843704
[TBL] [Abstract][Full Text] [Related]
6. The beta-adrenergic receptors.
Wallukat G
Herz; 2002 Nov; 27(7):683-90. PubMed ID: 12439640
[TBL] [Abstract][Full Text] [Related]
7. Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling.
Zhang X; Szeto C; Gao E; Tang M; Jin J; Fu Q; Makarewich C; Ai X; Li Y; Tang A; Wang J; Gao H; Wang F; Ge XJ; Kunapuli SP; Zhou L; Zeng C; Xiang KY; Chen X
Circ Res; 2013 Feb; 112(3):498-509. PubMed ID: 23104882
[TBL] [Abstract][Full Text] [Related]
8. E2F6 protein levels modulate drug induced apoptosis in cardiomyocytes.
Major JL; Salih M; Tuana BS
Cell Signal; 2017 Dec; 40():230-238. PubMed ID: 28964969
[TBL] [Abstract][Full Text] [Related]
9. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.
Zhang T; Maier LS; Dalton ND; Miyamoto S; Ross J; Bers DM; Brown JH
Circ Res; 2003 May; 92(8):912-9. PubMed ID: 12676814
[TBL] [Abstract][Full Text] [Related]
10. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
[TBL] [Abstract][Full Text] [Related]
11. Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.
Oudit GY; Crackower MA; Eriksson U; Sarao R; Kozieradzki I; Sasaki T; Irie-Sasaki J; Gidrewicz D; Rybin VO; Wada T; Steinberg SF; Backx PH; Penninger JM
Circulation; 2003 Oct; 108(17):2147-52. PubMed ID: 12963636
[TBL] [Abstract][Full Text] [Related]
12. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.
Malekar P; Hagenmueller M; Anyanwu A; Buss S; Streit MR; Weiss CS; Wolf D; Riffel J; Bauer A; Katus HA; Hardt SE
Hypertension; 2010 Apr; 55(4):939-45. PubMed ID: 20177000
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
14. Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
Hille S; Dierck F; Kühl C; Sosna J; Adam-Klages S; Adam D; Lüllmann-Rauch R; Frey N; Kuhn C
Cardiovasc Res; 2016 Jun; 110(3):381-94. PubMed ID: 27056896
[TBL] [Abstract][Full Text] [Related]
15. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.
Condorelli G; Drusco A; Stassi G; Bellacosa A; Roncarati R; Iaccarino G; Russo MA; Gu Y; Dalton N; Chung C; Latronico MV; Napoli C; Sadoshima J; Croce CM; Ross J
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12333-8. PubMed ID: 12237475
[TBL] [Abstract][Full Text] [Related]
16. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
[TBL] [Abstract][Full Text] [Related]
17. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG
J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling.
Akhter SA; Milano CA; Shotwell KF; Cho MC; Rockman HA; Lefkowitz RJ; Koch WJ
J Biol Chem; 1997 Aug; 272(34):21253-9. PubMed ID: 9261135
[TBL] [Abstract][Full Text] [Related]
19. Serial alterations of beta-adrenergic signaling in dilated cardiomyopathic hamsters: possible role of myocardial oxidative stress.
Nishizawa T; Iwase M; Kanazawa H; Ichihara S; Ichihara G; Nagata K; Obata K; Kitaichi K; Yokoi T; Watanabe M; Tsunematsu T; Ishikawa Y; Murohara T; Yokota M
Circ J; 2004 Nov; 68(11):1051-60. PubMed ID: 15502388
[TBL] [Abstract][Full Text] [Related]
20. Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.
Najafi A; Sequeira V; Helmes M; Bollen IA; Goebel M; Regan JA; Carrier L; Kuster DW; Van Der Velden J
Cardiovasc Res; 2016 May; 110(2):200-14. PubMed ID: 26825555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
